Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 3/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13060562 | 1.00 | KCNN4 (0.33) | KCNN4KCNA5PGRKDM4CSLC6A4 | |
| SCHEMBL13060518 | 1.00 | KCNN4 (0.33) | KCNN4KCNA5PGRKDM4CSLC6A4 | |
| SCHEMBL13060519 | 0.98 | KCNN4 (0.37) | KCNN4KCNA5PGRKDM4CMEN1 | |
| SCHEMBL13060317 | 0.98 | SLC6A4 (0.32) | KCNN4KCNA5PGRKDM4CSLC6A4 | |
| SCHEMBL13060289 | 0.98 | KCNN4 (0.37) | KCNN4KCNA5PGRKDM4CMEN1 | |
| SCHEMBL13060517 | 0.98 | KCNN4 (0.37) | KCNN4KCNA5PGRKDM4CMEN1 | |
| SCHEMBL13004407 | 0.98 | KCNN4 (0.37) | KCNN4KCNA5PGRKDM4CMEN1 | |
| SCHEMBL13004391 | 0.97 | KDM4C (0.32) | KCNN4KCNA5PGRKDM4C | |
| SCHEMBL13060287 | 0.92 | KDM4C (0.32) | KCNN4KCNA5PGRKDM4CSLC6A4 | |
| SCHEMBL13004422 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7846558-B2 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | SFC CO., LTD. (KR) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080203905-A1 | Blue light emitting compound and organic electroluminescent device using the same | TYR, CYBA, CRY2 | KCNN4 604/4885KCNA5 186/4885PGR 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.